Every infusion day produces two kinds of charges: the drug, billed in HCPCS units, and the administration, coded by a hierarchy. Hematology adds iron infusions and years of follow-up for blood disorders. Small errors in units or sequence add up quickly at oncology drug prices.
Book a demoMedical oncology and hematology share the same infusion rules, with different drugs and visit patterns.
CMS allows one initial administration code per day unless protocol requires a second IV site. Later pushes and infusions use subsequent or concurrent codes, and chemotherapy, therapeutic infusions, and hydration each have their own code groups.
Drugs are billed in HCPCS units, which rarely match the dose in milligrams. Discarded amounts from single-dose vials go on a separate line with the JW modifier, and Medicare requires the JZ modifier when nothing was discarded.
A significant, separately identifiable visit on an infusion day is billed with modifier 25. Hematology follow-up for anemia, clotting disorders, and blood cancers can run for years and needs its own visit documentation.
Oncology billing depends on infusion records, drug purchasing, and authorizations that often live with different people.
Your physicians and infusion nurses document orders, start and stop times, doses, and wastage. Physicians approve codes before submission.
If the fit is confirmed, Taiga would draft administration and drug codes from those records, scrub claims for unit and modifier errors, check eligibility, and work every denial and appeal.
Drug purchasing, prior authorization, and patient financial assistance often sit with practice staff or a specialty pharmacy, and oral cancer drugs may route through a pharmacy benefit. Agree who owns each.
Bring de-identified infusion records and a few denied drug claims. Keep patient details out of the booking form.
Say whether treatment runs in your own infusion suite, a hospital outpatient department, or both.
Describe buy-and-bill, white bagging, or specialty pharmacy by payer, and how NDCs and units are captured.
Sort recent denials by reason: units, modifiers, authorization, or medical necessity. That shows where the work is.
Worth a conversation if your practice runs its own infusion suite, bills its own claims, and loses hours to unit math and drug denials. There is no EHR migration involved.
Infusions given in a hospital outpatient department are billed by the hospital. This page covers the practice's own office-based claims.
Hematology and oncology are not on Taiga's public specialty list. Bring your infusion and clinic mix and you will get a plain answer on fit.
Use JW on a separate line for the discarded amount from a single-dose container, and JZ on the administered line when nothing was discarded. JW is not allowed when the dose is smaller than one billing unit.
Generally no. CMS allows a second initial code only when protocol requires two separate IV sites or the patient returns for a separately identifiable service.
Yes, if it is significant and separately identifiable from the administration. It is reported with modifier 25 and documented on its own.
Share a de-identified treatment day, from orders to wastage. Taiga will show how it would code and follow it, and say plainly whether it fits.
System guides show possible billing handoffs, not proven specialty compatibility.